Benjamin N Rome

opleiding gevolgd aan: Harvard Medical School, Brown-universiteit

beroep: onderzoeker

Series

There is nothing here

Create a new serie

Werken

There is nothing here

Create a new work

Artikels 25

Date

Titel

Auteurs

2020-02-03

Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary

Aaron S Kesselheim, Benjamin N Rome
2020-01-30

Reply to Boucher, et al

Aaron S Kesselheim, Benjamin N Rome
2020-03-06

Federal Spending on Off-Patent Drugs That Lack Generic Competition

Benjamin N Rome, Aaron S Kesselheim
2020-04-14

Drug Evaluation during the Covid-19 Pandemic

Benjamin N Rome, Jerry Avorn
2020-07-12

Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018

Aaron S Kesselheim, Benjamin N Rome
2020-07-20

US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate

Aaron S Kesselheim, Benjamin N Rome, Frazer A Tessema
2020-07-01

Drug Prices, Rebates, and Discounts

Aaron S Kesselheim, Benjamin N Rome
2020-11-13

Sex-Based Role Misidentification and Burnout of Resident Physicians: An Observational Study

Benjamin N Rome
2020-12-21

Non-Warfarin Oral Anticoagulant Copayments and Adherence in Atrial Fibrillation:A Population-Based Cohort Study

Aaron S Kesselheim, Joshua J Gagne, Jerry Avorn, Benjamin N Rome
2019-10-20

Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis

Benjamin N Rome, Aaron S Kesselheim
2019-10-24

Effect of Shared Electronic Health Records on Duplicate Imaging after Hospital Transfer

Benjamin N Rome
2019-10-29

Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center

Melissa G Lechner, Shervin Tabrizi, Lauren Sinnenberg, Robert J Glynn, Benjamin N Rome, Abraar Karan
2019-08-26

Use of "Doctor" Badges for Physician Role Identification During Clinical Training

Benjamin N Rome
2017-01-18

Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers

Aaron S Kesselheim, Benjamin N Rome, Jerry Avorn
2014-01-01

Approval of high-risk medical devices in the US: implications for clinical cardiology

Benjamin N Rome, Aaron S Kesselheim
2014-02-26

A comparison of patient-reported and measured range of motion in a cohort of total knee arthroplasty patients

Benjamin N Rome, E Losina, Jeffrey N Katz
2014-01-01

FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012

Benjamin N Rome, Aaron S Kesselheim
2013-03-18

Surgery versus physical therapy for a meniscal tear and osteoarthritis

Christine Chaisson, Morgan H Jones, Emily Reinke, Benjamin N Rome, E Losina, Jeffrey N Katz, Daniel H Solomon, John Wright, Rick W. Wright
2013-05-06

Placing a price on medical device innovation: the example of total knee arthroplasty

A. David Paltiel, Benjamin N Rome, E Losina, Jeffrey N Katz, Daniel H Solomon
2013-10-12

The AViKA (Adding Value in Knee Arthroplasty) postoperative care navigation trial: rationale and design features

E Losina, Benjamin N Rome, Jeffrey N Katz, John Wright
2013-03-01

Estimating the burden of total knee replacement in the United States

Benjamin N Rome, E Losina, Jeffrey N Katz, William M Reichmann, John Wright
2013-05-01

Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US.

E Losina, David Hunter, Joanne M Jordan, Jeffrey N Katz, William M Reichmann, Benjamin N Rome, Daniel H Solomon
2013

Epidemiology of Ageing (Socioeconomic Impact)

E Losina, Benjamin N Rome
2012-02-01

The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic

E Losina, Jeffrey N Katz, Benjamin N Rome, John Wright
2011-10-01

Medical device innovation--is "better" good enough?

A. David Paltiel, Benjamin N Rome, E Losina, Jeffrey N Katz, Daniel H Solomon

Human - wd:Q82093817

Welcome to Inventaire

de bibliotheek van je vrienden en communities

meer leren